These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 22301003)

  • 1. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers.
    Jia L; Shen J; Zhang D; Duan C; Liu G; Zheng D; Tian X; Liu Y; Zhang Q
    Int J Biol Macromol; 2012 Apr; 50(3):523-9. PubMed ID: 22301003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo studies on the oridonin-loaded nanostructured lipid carriers.
    Zheng D; Dai W; Zhang D; Duan C; Jia L; Liu Y; Zhang Q
    Drug Deliv; 2012 Aug; 19(6):286-91. PubMed ID: 22928767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization and pharmacokinetics of Amoitone B-loaded long circulating nanostructured lipid carriers.
    Luan J; Zhang D; Hao L; Qi L; Liu X; Guo H; Li C; Guo Y; Li T; Zhang Q; Zhai G
    Colloids Surf B Biointerfaces; 2014 Feb; 114():255-60. PubMed ID: 24211416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC).
    Doktorovová S; Araújo J; Garcia ML; Rakovský E; Souto EB
    Colloids Surf B Biointerfaces; 2010 Feb; 75(2):538-42. PubMed ID: 19879736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system.
    Dai W; Zhang D; Duan C; Jia L; Wang Y; Feng F; Zhang Q
    J Microencapsul; 2010 May; 27(3):234-41. PubMed ID: 20113167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of oridonin.
    Zheng D; Duan C; Zhang D; Jia L; Liu G; Liu Y; Wang F; Li C; Guo H; Zhang Q
    Int J Pharm; 2012 Oct; 436(1-2):379-86. PubMed ID: 22732673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and in vitro/in vivo evaluation of 17-allylamino-17-demethoxygeldanamycin (17AAG)-loaded PEGylated nanostructured lipid carriers.
    Wang Z; Wang J; Yang S; Hou S
    Drug Dev Ind Pharm; 2016 Jan; 42(1):91-98. PubMed ID: 25853294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation.
    Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G
    Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats.
    Zhang S; Wang J; Pan J
    Drug Deliv; 2016 Nov; 23(9):3696-3703. PubMed ID: 27749105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
    Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
    J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption.
    Zhou X; Zhang X; Ye Y; Zhang T; Wang H; Ma Z; Wu B
    Int J Pharm; 2015 Feb; 479(2):391-8. PubMed ID: 25556104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization, in vitro and in vivo evaluation of PEGylated oridonin conjugates.
    Shen J; Zhang D; Zhao Z; Jia L; Zheng D; Liu G; Hao L; Zhang Q; Tian X; Li C; Guo H
    Int J Pharm; 2013 Nov; 456(1):80-6. PubMed ID: 23973480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokinetic studies.
    Jia L; Zhang D; Li Z; Duan C; Wang Y; Feng F; Wang F; Liu Y; Zhang Q
    Colloids Surf B Biointerfaces; 2010 Oct; 80(2):213-8. PubMed ID: 20621458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEGylated nanostructured lipid carriers (PEG-NLC) as a novel drug delivery system for biochanin A.
    Wang L; Luo Q; Lin T; Li R; Zhu T; Zhou K; Ji Z; Song J; Jia B; Zhang C; Chen W; Zhu G
    Drug Dev Ind Pharm; 2015; 41(7):1204-12. PubMed ID: 25010850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanostructured lipid carriers as a delivery system of biochanin A.
    Wang Q; Cheng H; Zhou K; Wang L; Dong S; Wang D; Chen W
    Drug Deliv; 2013 Nov; 20(8):331-7. PubMed ID: 24111887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of silybin-loaded nanostructured lipid carriers.
    Jia LJ; Zhang DR; Li ZY; Feng FF; Wang YC; Dai WT; Duan CX; Zhang Q
    Drug Deliv; 2010 Jan; 17(1):11-8. PubMed ID: 19941406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and characterization of Amoitone B-loaded nanostructured lipid carriers for controlled drug release.
    Luan J; Zhang D; Hao L; Li C; Qi L; Guo H; Liu X; Zhang Q
    Drug Deliv; 2013 Nov; 20(8):324-30. PubMed ID: 24032657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of galactosylated bovine serum albumin nanoparticles for liver-targeted delivery of oridonin.
    Li C; Zhang D; Guo H; Hao L; Zheng D; Liu G; Shen J; Tian X; Zhang Q
    Int J Pharm; 2013 May; 448(1):79-86. PubMed ID: 23518367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEGylated long circulating nanostructured lipid carriers for Amoitone B: preparation, cytotoxicity and intracellular uptake.
    Luan J; Yang X; Chu L; Xi Y; Zhai G
    J Colloid Interface Sci; 2014 Aug; 428():49-56. PubMed ID: 24910034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.
    Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW
    Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.